DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

Monday, 6 April 2015

Susan Mayne, Ph.D. Director of FDA’s Center for Food Safety and Applied Nutrition


Susan Mayne
Susan Mayne, Ph.D.
Susan Mayne, Ph.D. Director of FDA’s Center for Food Safety and Applied Nutrition
She is  passionate about food safety and nutrition and their role in public health. I especially enjoy the intersection of science and policy, leading me to recently relocate to the FDA.

Education

ELAM (Executive Leadership for Academic Medicine)


Experience

Director, Center for Food Safety and Applied Nutrition

FDA
January 2015 – Present College Park, Maryland

C.-E.A. Winslow Professor of Epidemiology

Yale University School of Medicine
1988 – January 2015 (27 years)Yale School of Public Health
Susan T. Mayne joined the U.S. Food and Drug Administration (FDA) as the new director of the Center for Food Safety and Applied Nutrition (CFSAN), replacing her predecessor Michael Landa, who led the center for more than four years.
Susan T. Mayne is C.-E.A. Winslow Professor of Epidemiology with tenure and Chair, Department of Chronic Disease Epidemiology at the Yale School of Public Health.
Dr. Mayne is also Associate Director of the Yale Comprehensive Cancer Center, being responsible for Population Sciences.
She also directs a pre-doctoral training program at Yale in Partnership with the U.S. National Cancer Institute, to train students in modern methodologies for evaluating lifestyle determinants of human cancer risk, with an emphasis on nutritional, environmental, and occupational determinants, including their interactions with genetic factors.
Dr. Mayne earned a Ph.D. in nutritional biochemistry from Cornell University, with minors in biochemistry and toxicology, and a B.A. in chemistry from the University of Colorado.
Dr. Mayne is a fellow of the American College of Epidemiology, and of the Executive Leadership in Academic Medicine (ELAM) Program for Women. She has authored or co-authored over 180 articles/book chapters.
She also has served on several editorial boards including the Journal of NutritionCancer Epidemiology, Biomarkers and Prevention, and Nature Reviews Clinical Oncology.
Dr. Mayne has served on several National Academy of Sciences committees, including most recently the Committee that established Dietary Reference Intakes for Vitamin D and Calcium.
She is currently on the Food and Nutrition Board of the National Academy of Sciences, and recently completed a 5-year term on the Board of Scientific Counselors for the U.S. National Cancer Institute. Her research emphasizes lifestyle determinants of human cancer risk.
Mayne certainly boosts the academic credentials of an Ivy League scholar. CFSAN’s new director has researched the role of food, nutrition and obesity as risks for chronic disease, and she is the author or co-author of more than 200 scientific publications, according to FDA. She received a B.A. in chemistry from the University of Colorado, and went on to earn a Ph.D. in nutritional sciences, with minors in biochemistry and toxicology, from Cornell University.
“While I make no claims as an expert on food safety, I studied toxicology while earning my Ph.D., and have conducted research into relationships between chemical contaminants and cancer risk, as well as studying microbes and their role in human cancer,” Mayne said in the Q&A. “Thus, I think about things from the perspective of both benefits and risks, and am equally interested in both areas.”
Mayne grew up in rural Colorado. She understands agriculture and comes from a health-conscious family. She said her grandmother lived to be one year shy of age 100 and produced most of her food on a farm in rural Pennsylvania. Mayne’s dad had a small ranch in Colorado where he raised cattle. She characterized her 80-something-year-old mom as “the image of successful aging.”
“She chooses healthy foods, is physically active daily, and frequently sends me pictures of her hikes in the Colorado mountains,” Mayne wrote.

Susan Mayne, PhD

C.-E.A. Winslow Professor of Epidemiology (Chronic Diseases)
Susan T. Mayne, Ph.D., an expert in the lifestyle determinants of cancer risk, has been named the C.-E.A. Winslow Professor of Epidemiology at the Yale School of Public Health (YSPH).
Mayne’s research has emphasized the role of dietary factors in the etiology of several major cancers. She also studies other lifestyle factors, such as tobacco and alcohol use, and their interaction with genetics in cancer risk.
Recently, Mayne co-authored a study that found that indoor tanning significantly raises the risk of an increasingly common form of skin cancer in young people. Mayne and colleagues at the School of Public Health reported online in the Journal of the American Academy of Dermatology in December that people under the age of 40 who had tanned indoors had a 69 percent increased risk of early-onset basal cell carcinoma. The team found that the association was strongest among women, and that the risk increased with years of tanning use.
Mayne is head of the Division of Chronic Disease Epidemiology, which includes 28 faculty members. She is also associate director of Yale Cancer Center, where she is responsible for Population Sciences. Mayne, who earned her doctorate from Cornell University, has led Yale’s Cancer Prevention and Control Research Program for 17 years to record-high levels of National Institutes of Health (NIH) funding and productivity. She developed the Yale-National Cancer Institute partnership, which gives faculty and students access to important national cohort studies for research, as well as an NIH-funded training program in cancer epidemiology and genetics, now entering its ninth year. She has received the Distinguished Teaching Award at YSPH.
A member of several editorial boards, Mayne is a fellow of the American College of Epidemiology and of the Executive Leadership in Academic Medicine Program for Women. She has authored or co-authored over 170 articles and book chapters.
The C.-E.A. Winslow Memorial Fund was established in 1958 by an anonymous donor to support the work of a professor in the Department of Public Health (a precursor to YSPH). It recognizes Charles-Edward Amory Winslow, M.S., Dr.Ph., who served as chair of the department from its founding in 1915 until his retirement in 1945. A scholar with an international reputation and a firm belief in the philosophy of disease prevention, Winslow profoundly influenced both Yale’s department and the burgeoning field of public health.

From the New CFSAN Director: Reflections on My First Two Months

By: Susan Mayne, Ph.D.
I have been the director of FDA’s Center for Food Safety and Applied Nutrition (CFSAN) for two months now. What I have enjoyed the most about this new job has been getting to know the people in CFSAN, who come from incredibly varied and interesting backgrounds. I am truly impressed by their commitment to excellence and dedication to our mission to protect and promote public health.

I have also been struck by the depth and breadth of expertise involved in every initiative CFSAN undertakes. So many scientific disciplines are involved: We rely on the insights of our medical officers, toxicologists, epidemiologists, biologists, chemists, behavioral scientists, and nutritionists. Working with our scientists are our policy and communications experts, economists and lawyers. We all have the same goal: to give the safety of food and cosmetics and nutrition issues the thorough and careful consideration they deserve.
We stand on two legs: strong science and our ability to create policy and regulatory solutions to address public health concerns. The scientific fields in which we work, from genomics to toxicology, are advancing rapidly. The use of new technologies can make our science better and help us to get the information we need more quickly. Yet the constant evolution and adoption of new scientific methods can also pose unique challenges — for example, in interpreting trends in food safety and foodborne illness.
When considering the science of food and cosmetic safety, we assess the scientific certainty, severity, and likelihood of any given risk, and identify those people who would be most vulnerable. We consider what additional research can be undertaken to better clarify the science for decision-making, and use what we currently understand to determine whether the risk can be avoided.
For each issue, we need to examine the full range of options, ranging from consumer education to regulation to enforcement. For regulatory options we work with our legal teams to consider what is possible within our authorities. What are we empowered to do and how does our work intersect with that of other federal agencies? If we take an action, what is the international context, and are there foreign trade implications? What are the views of groups that will be most affected by our decisions, on both the consumer and industry sides? What are the costs and benefits? Have we thoughtfully considered how to ensure high levels of compliance?
I have observed with a great sense of satisfaction how we work together with other federal partners. For example, leaders from the Centers for Disease Control and Prevention (CDC) visited our center recently to share information and discuss how we can best support each other in our joint commitment to food safety. In the brief time I have been here, I have also observed interactions with the U.S. Department of Agriculture, the National Institutes of Health, and the Environmental Protection Agency.
CFSAN’s work is funded by taxpayers and affects people’s lives every day. Our work has real consequences for consumers, businesses, and industry. I have learned the importance of engaging in meaningful conversations with those outside of government, who are affected by our decisions. As we talk to our industry stakeholders, we benefit from their expertise and better understand the real-world constraints they face, and that ultimately helps us to put forth more effective policy. Similarly, we value hearing the perspectives of consumers, medical groups, and the scientific community, which often highlight areas where additional FDA focus is needed to protect public health. In our communications, we strive to accurately convey the risks and/or benefits of any food or product, and to rapidly communicate any emerging health concerns.
I have observed an amazing array of public health issues coming across my desk at CFSAN over the past two months. I am energized by the diverse breadth and depth of activity, and look forward to the challenges and opportunities ahead, and to sharing my thoughts and experiences with you onTwitter and in future blog posts.
Susan Mayne is the Director of FDA’s Center for Food Safety and Applied Nutrition

From left to right: Avery LaChance, Leah Ferrucci, Lisa Davis, Susan Mayne





University of Maryland, College Park



    1. Map of college park maryland

Saturday, 4 April 2015

Dr Rakeshwar Bandichhor

Dr. Rakeshwar Bandichhor  Director API - R&D,
Dr Reddy' laboratories
rakeshwarb@drreddys.com
Rakeshwar Bandichhor
Director, API, R&D
Dr. Reddy's Laboratories
India
Dr. Reddys Laboratories
 
Biography
Rakeshwar Bandichhor holds a doctorate in Chemistry from University of Lucknow/University of Regensburg, Germany and worked as Postdoctoral Fellow at University of Regensburg, Germany, University of Pennsylvania and Texas A&M University. Dr. Rakeshwar has more than 150 papers including patents and book chapters published/accepted in various International Journals and contributed to more than 60 academic national and international conferences. He has won the various awards in his career
Dr. Rakeshwar has more than 80 papers including patents and book chapters published/accepted in various International Journals. Notably, in the area of Organic Chemistry, Dr. Rakeshwar has coauthored a chapter in the book entitled “Green Chemistry in Pharmaceutical industry”.
He has won the various awards in his career e.g. Chairman Excellence Award in the category of individual functional excellence, Best Cost Leadership Award  for the development of Lopinavir, Ritonavir & their components and Anveshan Award at Dr. Reddy’s. As a part of organizational building efforts, he also supervises master’s & Ph.D. students in their dissertations. He has been invited in several conferences e.g. IIT-Mumbai, IGCW-2009, BIT-Ranchi, BITS Pilani, 9th Heterocyclic Conference, University of Florida, JNTU-Hyderabad, ISCB-2011, Apollo Hospitals Educational & Research Foundation, Hyderabad etc. to deliver  lectures. He is also currently acting as an Associate  Editor of GERF Bulletin of Bioscience.
Recently, he has become a member National Advisory Board of Indian Society of Chemists and Biologists.


Dr.Rakeshwar Bandichhor at IGCW-09

Publications

Role of Generic Pharmaceutical Industry in Healthcare
Rakeshwar Bandichhor
Editorial: Chem Sci J 2014, 5:e101
doi: 10.4172/2150-3494.10000e101
Research Perspective in Academia and Generic Pharmaceutical Industry
Rakeshwar Bandichhor
Editorial: Organic Chem Current Res 2012, 1:e104
doi: 10.4172/2161- 0401.1000e104


http://greenchemistry.conferenceseries.com/ocm/2015/rakeshwar-bandichhor-dr-reddy-s-india


Experience



Director

Dr. Reddy's Laboratories
 – Present 


Associate Director

Dr. Reddy's Laboratories
 –  (2 years 6 months)


Senior Manager

Dr. Reddy's Laboratories
 –  (4 years)


speaker

Green cemistry
 –  (1 year)


Scientist

Ranbaxy-CDRI-Lucknow University-University of Regensburg-University of Pennsylvania-Texas A&M
 –  (9 years)
Postdoctoral Research Associate, Department of Chemistry, Texas A&M University June 2005-2006
(1 and ½” YR)
Advisor: Dr. Kevin Burgess, Rachal Professor of Chemistry, College Station, USA
Synthesis of “Through Bond Energy Transfer Cassettes”
Postdoctoral Fellow, Roy and Diana Vegelos Laboratories for Advanced Science and Technology,
University of Pennsylvania, Jan 2004-May2005 (NEARLY “1 and ½” YR)
Advisor: Dr. Marisa C. Kozlowski, Professor of Chemistry, Philadelphia, USA
Studies towards Total Synthesis of Purpuromycin and its Derivatives
Postdoctoral Fellow, University of Regensburg, March 2002 to December 2003 (NEARLY “2” YRS)
Advisor: Dr. Oliver Reiser, Professor of Chemistry, Regensburg, Germany
Studies directed to Total Synthesis of Arglabin and Ixerin Y
Graduate Research Student, University of Regensburg, March 2001 to March 2002 (“1” YR)
Advisor: Dr. Oliver Reiser, Professor of Chemistry, Regensburg, Germany
Enantioselective Synthesis of Paraconic acids (Ph.D. Work).
Post Graduate Research Trainee (PGRT), Central Drug Reseach Institute, Lucknow, India,
August 1999 to February 2001
Advisor: Dr. S. N. Rastogi, Retired Deputy Director, Division of Medicinal Chemistry
Synthesis of Nonsteroidal Antifertility Regulating Agents.
Post Graduate Research Assistant, University of Lucknow, India, October 1998 to July 1999
Advisor: Dr. V. K. Tandon, Professor of Organic Chemistry
Synthesis of 1,3,4-Oxadiazoles and Diazete type of N-oxide donors.
Project Trainee, Central Drug Reseach Institute, Lucknow, India, June 1998 to September 1998
Advisor: Dr. Kanchan Hajela, Deputy Director, Division of Medicinal Chemistry
Synthesis of Possible Nonsteroidal Antifertility Regulating Agents.
Project Trainee, Ranbaxy Research Laboratories, Gurgaon, India, May 1997 to June 1997
Advisor: Dr. Naresh, Head of the Research and Development Division
Synthesis of b-Lactam Antibiotics and Derivatives of Picoline


Student

University of Regensburg
 –  (3 years)


Researcher

CDRI
 –  (2 years)



Education





Innovation Plaza, IPDO, R&D , Dr. Reddy's Laboratories Ltd.
Displaying image.png

LEVETIRACETAM GREEN PROCESS

Displaying image.png
Displaying image.png


 An alternate synthesis of levetiracetam
Ravikumar Mylavarapu a , Ramasamy Vijaya Anand a , Golla China Mala Kondaiah a , Lekkala
Amarnath Reddy a , Gade Srinivas Reddy a , Arnab Roy a , Apurba Bhattacharya a , Kagga
Mukkanti b & Rakeshwar Bandichhor a
a Innovation Plaza, IPDO, R&D , Dr. Reddy's Laboratories Ltd. , Survey Nos. 42, 45,46 & 54,
Bachupally, Qutubullapur, 500073, R.R. Dist, Andhra Pradesh, India
b Center for Environmental Science, Institute of Science and Technology , J.N.T. University ,
Kukatpally, Hyderabad, 500 072, Andhra Pradesh, India
Email: rakeshwarb@drreddys.com
Green Chemistry Letters and Reviews
Vol. 3, No. 3, September 2010, 225230
Ravikumar Mylavarapu , Ramasamy Vijaya Anand , Golla China Mala Kondaiah , Lekkala Amarnath Reddy ,
Gade Srinivas Reddy , Arnab Roy , Apurba Bhattacharya , Kagga Mukkanti & Rakeshwar Bandichhor (2010)
An alternate
synthesis of levetiracetam, Green Chemistry Letters and Reviews, 3:3, 225-230, DOI: 10.1080/17518251003716568
To link to this article: http://dx.doi.org/10.1080/17518251003716568